On August 21, 2026, a clinical trial update was recorded for a study involving substance P. The trial, registered as NCT06561828, is titled "Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making." It is listed as an Early Phase 1 study. Its current status is recruiting. Substance P remains classified as an unapproved compound used in research settings. No results have been posted for this trial at this time. The study record does not provide additional details on outcomes, dosing, or findings beyond its current recruiting status and phase designation. Readers interested in tracking this trial can refer to the official registry listing for further updates as the study progresses. For background information on substance P, readers can consult the compound overview.
Substance P Trial NCT06561828 Recruiting for Neuromodulation Study
See the full substance p overview
Source: https://clinicaltrials.gov/study/NCT06561828